Trial
NCT02806362
Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AbbVie
Collaborators
—
Condition
Chronic Hepatitis C Virus
Intervention
Ombitasvir/paritaprevir/ritonavir
Why stopped
Study halted prematurely, prior to enrollment of first participant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-05